ACUTA CAPITAL PARTNERS, LLC

Holdings History for Whitehawk Therapeutics, Inc. - Common stock (WHWK)

Symbol: WHWK on Nasdaq
Investment type: Equity / Common stock
Latest Disclosed Shares Owned: 1,921,297 shares
Security Ownership %: 7.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Anupam Dalal ownership in Whitehawk Therapeutics, Inc. Common stock (WHWK)

24 Jan 2025 - Anupam Dalal has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,921,297 shares of Whitehawk Therapeutics, Inc. Common stock (WHWK). This represents 7.8% ownership of the company. This is the first filing by ACUTA CAPITAL PARTNERS, LLC disclosing ownership of Whitehawk Therapeutics, Inc. Common stock (WHWK).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Anupam Dalal	7.8%		$2,958,797	1,921,297			$1.54	13D/A	19 Dec 2024	24 Jan 2025, 14:34

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	5.6%	0%	$8,253,173	3,410,402	0		$2.42	Q4 2025
30 Sep 2025	6.7%	0%	$6,479,764	3,410,402	0		$1.90	Q3 2025
30 Jun 2025	8.9%	0%	$6,377,452	3,410,402	0		$1.87	Q2 2025
31 Mar 2025	7%	+3.2%	$6,070,516	3,410,402	+1,561,000		$1.78	Q1 2025
31 Dec 2024	5.9%	0%	$5,834,863	1,849,402	0		$3.15	Q4 2024
30 Sep 2024	3.1%	0%	$3,809,768	1,849,402	0		$2.06	Q3 2024
30 Jun 2024	2.3%	0%	$2,700,127	1,849,402	0		$1.46	Q2 2024
31 Mar 2024	2.8%	0%	$4,327,601	1,849,402	0		$2.34	Q1 2024
31 Dec 2023	2.1%	0%	$3,735,792	1,849,402	0		$2.02	Q4 2023
30 Sep 2023	6.5%	0%	$8,951,106	1,849,402	0		$4.84	Q3 2023
30 Jun 2023	8.6%	0%	$12,649,910	1,849,402	0		$6.84	Q2 2023
31 Mar 2023	10%	0%	$13,389,670	1,849,402	0		$7.24	Q1 2023
31 Dec 2022	13%	0%	$19,622,228	1,849,402	0		$10.61	Q4 2022
30 Sep 2022	12%	+2%	$26,132,000	1,849,402	+320,000	+21%	$14.13	Q3 2022
30 Jun 2022	11%	0%	$18,842,000	1,529,402	0		$12.32	Q2 2022
31 Mar 2022	12%	0%	$25,954,000	1,529,402	0		$16.97	Q1 2022
31 Dec 2021	16%	0%	$36,935,000	1,529,402	0		$24.15	Q4 2021
30 Sep 2021	16%	+16%	$44,919,000	1,529,402	+1,529,402	NEW	$29.37	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.